查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球脊柱融合設備市場 - 2023-2030年
市場調查報告書
商品編碼
1290359

全球脊柱融合設備市場 - 2023-2030年

Global Spinal Fusion Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概況

全球脊柱融合器市場規模在2022年達到76.664億美元，預計到2030年將見證有利可圖的成長，達到108.274億美元。在預測期內（2023-2030年），全球脊柱融合設備市場的年復合成長率為4.5%。

脊柱融合術通常用於治療各種脊柱疾病，包括退行性椎間盤疾病、椎管狹窄、脊柱骨折、脊柱側彎和脊柱不穩定。該手術涉及使用植入物或骨移植物連接或融合兩個或多個相鄰的椎體，在它們之間建立一個堅實的骨橋。

脊柱融合器市場受到以下因素的驅動：老齡化人口和肥胖人口的增加，意識和病人教育的成長，脊柱疾病的發病率增加，技術的進步，以及對微創手術的日益青睞。

市場動態

脊柱疾病的發病率不斷提高

脊柱疾病患病率的增加是在預測期內推動脊柱融合器械市場佔有率的主要因素。人口老齡化、久坐不動的生活方式和肥胖症是促使脊柱融合器產生機會的主要因素。

隨著全球人口的不斷老齡化，脊柱疾病的發病率預計將上升。與年齡有關的退行性疾病，如退行性椎間盤疾病和椎管狹窄，隨著年齡的成長而變得更加普遍。脊柱結構的退化，包括椎間盤、關節和韌帶，會促使疼痛、喪失活動能力和脊柱不穩定。

肥胖症發病率的上升與脊柱疾病風險的增加密切相關。過重的體重會給脊柱帶來額外的壓力，促使脊柱結構的加速磨損，並增加患退行性椎間盤疾病和脊柱骨關節炎等疾病的可能性。

高昂的治療費用

高昂的治療費用是脊柱融合領域的一個重要阻礙因素，會影響患者、醫療系統和脊柱融合器械的採用。脊柱融合手術是一個複雜的過程，涉及到專業醫療人員團隊、先進的手術設備和術後護理。手術的費用包括與手術室、麻醉、外科醫生費用、住院和康復有關的費用。

這些費用可能因手術的複雜性、醫療機構的位置和病人的具體需求等因素而有所不同。新的脊柱融合設備和技術的開發涉及大量的研究和開發工作，這可能促使更高的治療費用。這些成本通常會轉嫁到病人和醫療系統身上。

COVID-19影響分析

COVID-19大流行病對脊柱融合器械市場產生了重大影響。參與脊柱融合手術的脊柱外科醫生和醫護人員被重新安排到與COVID-19相關的活動中，包括病人護理、研究和疫苗接種工作。這種優先事項和資源的轉移可能促使脊柱融合手術的減少和新設備或技術的採用暫時放緩。

由於擔心在醫療機構中感染病毒，或認為住院和術後護理有風險，病人在大流行期間對接受選擇性手術猶豫不決。這種不願意接受脊柱融合手術的態度可能進一步促使了對脊柱融合器械需求的下降。

隨著疫苗接種工作的進展和醫療系統從大流行病的影響中恢復過來，預計會有積壓的脊柱融合手術被推遲。這種被壓抑的需求，再加上選擇性手術的恢復，可能會促使脊柱融合器械的需求在大流行後的時期出現反彈。

俄羅斯-烏克蘭衝突分析

俄烏衝突極大地影響了脊柱融合器的市場。衝突會產生重大的經濟後果，包括貨幣波動、通貨膨脹和購買力下降。這些經濟因素會影響醫療預算，有可能促使包括脊柱融合器在內的醫療設備支出減少。

衝突會擾亂醫療設備的供應鏈，包括脊柱融合設備。這兩個國家在醫療保健產品的製造和分銷方面都發揮著重要作用。運輸路線的任何中斷、邊境關閉或政治緊張局勢都可能促使脊柱融合器械供應的延遲或中斷。

目錄

第一章：方法和範圍

  • 研究方法
  • 報告的研究目標和範圍

第二章：定義和概述

第三章：執行摘要

  • 按產品類型抽查
  • 按手術地點分類
  • 按應用分類
  • 按終端用戶分類
  • 按地區分類

第4章：動態變化

  • 影響因素
    • 驅動因素
      • 脊柱疾病的發病率越來越高
      • 對微創手術的需求不斷增加
    • 限制因素
      • 治療費用高
      • 可供選擇的治療方法
    • 機會
      • 外科技術的進步
    • 影響分析

第五章：行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 監管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情況
    • COVID-19期間的情況
    • COVID-19之後的情況
  • 在COVID-19期間的定價動態
  • 需求-供應譜系
  • 大流行期間與市場有關的政府計劃
  • 製造商的戰略計劃
  • 結語

第七章：按產品類型

  • 椎弓根螺釘
  • 椎間盤
  • 骨移植
  • 脊柱融合刺激器
  • 其他產品

第8章：按手術位置分類

  • 頸椎融合器
  • 腰椎融合器
  • 胸椎融合器
  • 其它

第九章：按應用分類

  • 退行性椎間盤疾病
  • 脊柱滑脫症
  • 椎管狹窄症
  • 脊柱側彎
  • 脊柱外傷
  • 腫瘤
  • 其他

第十章：按終端用戶分類

  • 醫院
  • 非住院手術診所
  • 專業診所
  • 其他

第十一章：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 亞太其他地區
  • 中東和非洲

第十二章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 合併和收購分析

第十三章：公司簡介

  • Medtronic plc
    • 公司概述
    • 產品組合和描述
    • 財務概況
    • 主要發展情況
  • Johnson & Johnson
  • Stryker Corporation
  • NuVasive Inc.
  • Zimmer Biomet Holdings Inc.
  • Globus Medical Inc.
  • Spinal Elements Inc.
  • Xtant Medical Holdings Inc.
  • RTI Surgical Inc.
  • ATEC spine Inc.

第十四章：附錄

簡介目錄
Product Code: MD1636

Market Overview

The Global Spinal Fusion Devices Market size reached US$ 7,666.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 10,827.4 million by 2030. The global spinal fusion devices market is exhibiting a CAGR of 4.5% during the forecast period (2023-2030).

Spinal fusion is typically performed to treat various spinal conditions, including degenerative disc disease, spinal stenosis, spinal fractures, scoliosis, and spinal instability. The procedure involves joining or fusing two or more adjacent vertebrae using implants or bone grafts to create a solid bone bridge between them.

The spinal fusion devices market is driven by factors such as the rising aging population and obese population, growing awareness and patient education, increasing prevalence of spinal disorders, technological advancements, and growing preference for minimally invasive procedures.

Market Dynamics

Increasing Prevalence of Spinal Disorders

The increasing prevalence of spinal disorders is the major factor driving the spinal fusion devices market share during the forecast period. The aging population, sedentary lifestyle, and obesity are the major factors leading to creating a chance for spinal fusion devices.

As the global population continues to age, the prevalence of spinal disorders is expected to rise. Age-related degenerative conditions, such as degenerative disc disease and spinal stenosis, become more common with advancing age. The degeneration of spinal structures, including discs, joints, and ligaments, can lead to pain, loss of mobility, and spinal instability.

The rising prevalence of obesity is strongly linked to an increased risk of spinal disorders. Excess weight places additional stress on the spine, leading to accelerated wear and tear of spinal structures and an increased likelihood of developing conditions such as degenerative disc disease and spinal osteoarthritis.

High Treatment Costs

High treatment costs are a significant restraint in the field of spinal fusion and can impact patients, healthcare systems, and the adoption of spinal fusion devices. Spinal fusion surgery is a complex procedure that involves a team of specialized healthcare professionals, advanced surgical equipment, and postoperative care. The cost of the surgery includes expenses related to the operating room, anesthesia, surgeon fees, hospital stay, and rehabilitation.

These costs can vary depending on factors such as the complexity of the procedure, the location of the healthcare facility, and the patient's specific needs. The development of new spinal fusion devices and technologies involves significant research and development efforts, which can contribute to higher treatment costs. These costs are often passed on to patients and healthcare systems.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the spinal fusion devices market. Spinal surgeons and healthcare professionals involved in spinal fusion procedures were redirected to COVID-19-related activities, including patient care, research, and vaccination efforts. This shift in priorities and resources could have resulted in a decrease in spinal fusion surgeries and a temporary slowdown in the adoption of new devices or technologies.

Patients were hesitant to undergo elective surgeries during the pandemic due to concerns about contracting the virus in healthcare settings or the perceived risk associated with hospitalization and postoperative care. This reluctance to undergo spinal fusion procedures may have further contributed to the decline in demand for spinal fusion devices.

As vaccination efforts progress and healthcare systems recover from the pandemic's impact, there is expected to be a backlog of deferred spinal fusion surgeries. This pent-up demand, coupled with the resumption of elective surgeries, could lead to a rebound in the demand for spinal fusion devices in the post-pandemic period.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict significantly impacted the spinal fusion devices market. The conflict can have significant economic consequences, including currency fluctuations, inflation, and reduced purchasing power. These economic factors can influence healthcare budgets, potentially leading to reduced spending on medical devices, including spinal fusion devices.

The conflict can disrupt the supply chain of medical devices, including spinal fusion devices. Both countries play a significant role in the manufacturing and distribution of healthcare products. Any disruptions in transportation routes, border closures, or political tensions can lead to delays or interruptions in the availability of spinal fusion devices.

Segment Analysis

The global spinal fusion devices market is segmented based on product type, procedure location, application, end-user, and region.

Based on the Product Type, the Pedicle Screws Segment is Expected to Dominate the Market Share

Based on the product type, the pedicle screw segment is expected to dominate the market share accounting for 46.4% during the forecast period. Pedicle screws are widely used in spinal fusion surgeries to provide stability and support during the fusion process. Pedicle screws offer excellent stability by anchoring into the pedicles, which are bony protrusions on the vertebrae. This stability helps maintain proper alignment of the spine during the fusion process and promotes successful fusion.

Minimally invasive spinal fusion procedures have gained popularity due to their potential benefits, including smaller incisions, reduced muscle damage, and faster recovery. Pedicle screws are an essential component of minimally invasive approaches, enabling surgeons to achieve spinal fusion with less tissue disruption.

Geographical Analysis

North America Holds The Largest Market Share Of 38.5% Due To The Rising Prevalence Of Spinal Disorders And The Presence Of Major Players

North America holds the largest market share during the forecast period due to the rising prevalence of spinal disorders and the presence of major players. North America has a high prevalence of spinal disorders, including degenerative disc disease, herniated discs, and spinal stenosis. These conditions can cause severe pain and mobility issues, leading to the need for spinal fusion procedures. The increasing prevalence of these disorders drives the demand for spinal fusion devices in the region.

The presence of major players in this region, like Merck KGaA, Harvard Bioscience Inc. (BTX), Thermo Fisher Scientific, Inc., Bio-Rad Laboratories., and Lonza Group, are expected to boost the growth of the market over the forecast period.

Competitive Landscape

The major global players in the market include: Medtronic plc, Johnson & Johnson, Stryker Corporation, NuVasive Inc., Zimmer Biomet Holdings Inc., Globus Medical Inc., Spinal Elements Inc., Xtant Medical Holdings Inc., RTI Surgical Inc., and ATEC spine Inc.

Why Purchase the Report?

  • To visualize the global spinal fusion devices market segmentation based on product type, procedure location, application, end-user, and region and understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of spinal fusion devices market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global spinal fusion devices market report would provide approximately 54 tables, 46 figures, and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Procedure Location
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing prevalence of spinal disorders
      • 4.1.1.2. Increasing demand for minimally invasive procedures
    • 4.1.2. Restraints
      • 4.1.2.1. High treatment costs
      • 4.1.2.2. Availability of alternative treatment options
    • 4.1.3. Opportunity
      • 4.1.3.1. Advancements in surgical techniques
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Pedicle Screws*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Plates
  • 7.4. Bone grafts
  • 7.5. Spinal fusion stimulators
  • 7.6. Others

8. By Procedure Location

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 8.1.2. Market Attractiveness Index, By Procedure Location
  • 8.2. Cervical spinal fusion devices*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Lumbar spinal fusion devices
  • 8.4. Thoracic spinal fusion devices
  • 8.5. Others

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Degenerative Disk Disease*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Spondylolisthesis
  • 9.4. Spinal stenosis
  • 9.5. Scoliosis
  • 9.6. Spinal trauma
  • 9.7. Tumors
  • 9.8. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Ambulatory surgical clinics
  • 10.4. Specialty clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure Location
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtronic plc*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Johnson & Johnson
  • 13.3. Stryker Corporation
  • 13.4. NuVasive Inc.
  • 13.5. Zimmer Biomet Holdings Inc.
  • 13.6. Globus Medical Inc.
  • 13.7. Spinal Elements Inc.
  • 13.8. Xtant Medical Holdings Inc.
  • 13.9. RTI Surgical Inc.
  • 13.10. ATEC spine Inc.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us